New MS Drug Ocrevus Wins FDA Approval – NBCNews.com
NBCNews.com |
New MS Drug Ocrevus Wins FDA Approval
NBCNews.com The drug, called Ocrevus, is approved for use against the most common form of MS – the relapsing-remitting type. It’s also approved for primary progressive MS, a very aggressive form of the disease that affects 10 to 15 percent of MS patients. There … Ocrevus’ Journey from Defiant Idea to Game-Changing Treatment Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen FDA Approves First Drug to Treat Severe Multiple Sclerosis |
Powered by WPeMatico